Patents by Inventor Kuniaki Nakanishi

Kuniaki Nakanishi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating skin ulcers with vectors encoding hepatocyte growth factor
    Patent number: 7939504
    Abstract: The present invention relates to a therapeutic preventive agent that includes an angiogenic factor gene (such as hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), fibroblast growth f actor (FGF), and hypoxia inducible factor (HIF)) as its active ingredient, and the administration of such an agent into the targeted skin diseases-affected area.
    Type: Grant
    Filed: June 14, 2007
    Date of Patent: May 10, 2011
    Assignee: AnGes MG, Inc.
    Inventors: Ryuichi Morishita, Kuniaki Nakanishi, Yasufumi Kaneda, Hitoshi Kotani
  • METHOD OF TREATING SKIN WOUNDS WITH VECTORS ENCODING HEPATOCYTE GROWTH FACTOR
    Publication number: 20070264321
    Abstract: The present invention relates to a therapeutic preventive agent that includes an angiogenic factor gene (such as hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), fibroblast growth f actor (FGF), and hypoxia inducible factor (HIF)) as its active ingredient, and the administration of such an agent into the targeted skin diseases-affected area.
    Type: Application
    Filed: June 14, 2007
    Publication date: November 15, 2007
    Inventors: Ryuichi Morishita, Kuniaki Nakanishi, Yasufumi Kaneda, Hitoshi Kotani
  • Method of treating skin wounds with vectors encoding hepatocyte growth factor
    Patent number: 7247620
    Abstract: The present invention relates to a therapeutic preventive agent that includes an angiogenic factor gene (such as hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and hypoxia inducible factor (HIF)) as its active ingredient, and the administration of such an agent into the targeted skin diseases-affected area.
    Type: Grant
    Filed: May 9, 2002
    Date of Patent: July 24, 2007
    Assignee: Anges MG, Inc.
    Inventors: Ryuichi Morishita, Kuniaki Nakanishi, Yasufumi Kaneda, Hitoshi Kotani
  • Gene transfers of angiogenic factor for skin disease
    Publication number: 20040234481
    Abstract: The present invention relates to a therapeutic preventive agent that includes an angiogenic factor gene (such as hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and hypoxia inducible factor (HIF)) as its active ingredient, and the administration of such an agent into the targeted skin diseases-affected area.
    Type: Application
    Filed: May 17, 2004
    Publication date: November 25, 2004
    Inventors: Ryuichi Morishita, Kuniaki Nakanishi, Yasufumi Kaneda, Hitoshi Kotani